Société Pain Therapeutics, Inc. Nasdaq
Actions
US69562K5065
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/05/98 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 01/10/18 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 04/01/21 |
Michael Zamloot
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Director/Board Member | 65 | 01/06/98 | |
Robert Cook
LAW | General Counsel | 60 | 01/10/22 |
Michael Marsman
LAW | General Counsel | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/05/98 |
Robert Gussin
BRD | Director/Board Member | 86 | 01/03/03 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07/12/07 |
Director/Board Member | 92 | 01/09/98 | |
Richard Barry
BRD | Director/Board Member | 65 | 11/06/21 |
Director/Board Member | 65 | 01/06/98 | |
Claude Nicaise
BRD | Director/Board Member | 71 | 07/12 |
Robert Anderson
BRD | Director/Board Member | 58 | 07/12 |
Pierre Gravier
BRD | Director/Board Member | 39 | 07/12 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 47 976 166 | 44 808 216 ( 93,40 %) | 0 | 93,40 % |
Coordonnées société
Cassava Sciences, Inc.
6801 North Capital of Texas Highway Suite 300
78731, Austin
+512 501 2444
http://www.cassavasciences.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+20,63 % | 127 Md | |
+24,83 % | 27,67 Md | |
-20,17 % | 20,33 Md | |
-17,24 % | 16,79 Md | |
-18,07 % | 15,63 Md | |
-47,70 % | 14,65 Md | |
+11,92 % | 14,84 Md | |
+58,32 % | 14,43 Md | |
+149,98 % | 12,49 Md |